urea has been researched along with Pulmonary Fibrosis in 6 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may contribute to obstruction and hyperresponsiveness of the airways by inducing a reduction in the production of bronchodilatory nitric oxide (NO) that results from its competition with constitutive (cNOS) and inducible (iNOS) NO synthases for their common substrate." | 2.44 | Arginase and pulmonary diseases. ( Maarsingh, H; Meurs, H; Pera, T, 2008) |
| "Pulmonary fibrosis is a chronic disease." | 1.38 | The efficiency of a urotensin II antagonist in an experimental lung fibrosis model. ( Ceribasi, AO; Demir, T; Kaplan, DS; Kisacik, B; Onat, AM; Pehlivan, Y; Taysi, S; Turkbeyler, IH; Tutar, E, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onat, AM | 1 |
| Turkbeyler, IH | 1 |
| Pehlivan, Y | 1 |
| Demir, T | 1 |
| Kaplan, DS | 1 |
| Taysi, S | 1 |
| Ceribasi, AO | 1 |
| Tutar, E | 1 |
| Kisacik, B | 1 |
| Ammar, YA | 1 |
| Ismail, MM | 1 |
| El-Sehrawi, HM | 1 |
| Noaman, E | 1 |
| Bayomi, AH | 1 |
| Shawer, TZ | 1 |
| Maarsingh, H | 1 |
| Pera, T | 1 |
| Meurs, H | 1 |
| Roberts, CM | 1 |
| Cairns, D | 1 |
| Bryant, DH | 1 |
| Burke, WM | 1 |
| Yeates, M | 1 |
| Blake, H | 1 |
| Penny, R | 1 |
| Shelley, L | 1 |
| Zaunders, JJ | 1 |
| Breit, SN | 1 |
| Jones, KP | 2 |
| Reynolds, SP | 2 |
| Capper, SJ | 1 |
| Kalinka, S | 1 |
| Edwards, JH | 2 |
| Davies, BH | 2 |
| Peters, TJ | 1 |
1 review available for urea and Pulmonary Fibrosis
| Article | Year |
|---|---|
Arginase and pulmonary diseases.
Topics: Animals; Arginase; Arginine; Asthma; Cystic Fibrosis; Disease Models, Animal; Humans; Hypertension, | 2008 |
5 other studies available for urea and Pulmonary Fibrosis
| Article | Year |
|---|---|
The efficiency of a urotensin II antagonist in an experimental lung fibrosis model.
Topics: Animals; Bleomycin; Endothelin-1; Lung; Male; Pulmonary Fibrosis; Quinolines; Random Allocation; Rat | 2012 |
Novel pirfenidone analogues: synthesis of pyridin-2-ones for the treatment of pulmonary fibrosis.
Topics: Administration, Oral; Alanine Transaminase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspart | 2006 |
Changes in epithelial lining fluid albumin associated with smoking and interstitial lung disease.
Topics: Biomarkers; Bronchoalveolar Lavage Fluid; Citrates; Citric Acid; Connective Tissue Diseases; Epithel | 1993 |
Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung disease and control subjects.
Topics: Albumins; Bird Fancier's Lung; Bronchoalveolar Lavage Fluid; Female; Humans; Immunoglobulin G; Inter | 1991 |
A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with interstitial lung disease.
Topics: Albumins; Biomarkers; Bird Fancier's Lung; Bronchoalveolar Lavage Fluid; Humans; Male; Pulmonary Fib | 1990 |